Skip to main content
. 2021 Sep 13;12:651498. doi: 10.3389/fneur.2021.651498

Table 2.

Case 1 and 2 outcomes at baseline, mid- and end Treatment and mid- and end Control.

Outcome Case Baseline Mid treatment End treatment Mid control End control Follow up
BFI 1 5.67 1.56 1.00 6.78 6.33 7.00
2 4.33 5.89 2.33 2.78 3.89 4.56
ESS 1 3.00 1.00 2.00 1.00 1.00 0.00
2 11.00 6.00 7.00 6.00 11.00 7.00
FSS 1 5.22 2.22 2.11 3.67 5.78 5.67
2 2.33 3.56 2.00 2.11 3.11 3.33
HADS Depression 1 5.00 2.00 3.00 4.00 2.00 5.00
2 6.00 3.00 3.00 4.00 4.00 6.00
ISI 1 18.00 2.00 7.00 11.00 20.00 8.00
2 15.00 17.00 13.00 13.00 15.00 11.00
MEQ 1 34.00 49.00 42.00 38.00 39.00 41.00
2 72.00 74.00 70.00 73.00 72.00 70.00
PSQI Global 1 8.00 3.00 2.00 5.00 5.00 3.00
2 11.00 7.00 8.00 8.00 8.00 9.00
PVT Mean RT (ms) 1 344.44
2 310.44 300.03 314.75 288.65 268.51
PVT Fastest 10% RT (ms) 1 281.63
2 237.02 238.14 223.33 233.77 217.24
POPS (Objective) 1 −0.25 0.10 −0.13 0.96 −0.12 0.40
2 1.06 1.58 0.92 0.09 0.51 0.50
Sleep Onsetac 1 22:43 00:48 00:14 01:09
2 21:39 20:52 21:42 21:37
Sleep Offsetac 1 06:45 07:04 08:23 07:59
2 05:50 03:41 05:25 04:34
SOLbc 1 10.59 60.90 6.69 7.17
2 5.11 8.00 7.94 10.21
WASObc 1 46.53 11.97 21.78 19.36
2 69.31 69.87 73.41 68.50
TSTbc 1 435.48 364.00 468.36 470.42
2 421.85 339.60 389.35 347.86
Sleep efficiency (%)c 1 87.45 74.68 90.89 90.78
2 83.74 75.76 81.27 79.09

BFI, Brief Fatigue Inventory; ESS, Epworth Sleepiness Scale; FSS, Fatigue Severity Scale; HADS, Hospital Anxiety and Depression Scale; ISI, Insomnia Severity Index; MEQ, Morningness Eveningness Questionnaire; PSQI, Pittsburgh Sleep Quality Index; POPS, Participation Objective Participation Subjective; PVT, Psychomotor Vigilance Task; SOL, Sleep onset latency; TST, Total sleep time; WASO, Wake after sleep onset. Some outcomes missing due to equipment failure.

a

Values represent real clock times, in 24 h time.

b

Outcome is in minutes.

c

Individual actigraphic sleep episodes were inspected and aligned with sleep diaries (see Supplementary Materials). Sleep outcome is derived from the average of data in mid- to end-treatment condition periods.